Elucidating Novel Immune and Genomic Markers for ALK (ENIGMA+)
ALK-positive lung cancer is a subtype of lung cancer which carries a genetic change in a gene called ALK (anaplastic lymphoma kinase). About 5% of lung cancers are ALK-positive. These ALK-positive lung cancers carry a genetic change which results in an abnormal ALK protein that tells the cancer to grow.
The purpose of this research study is to obtain and study tissue, saliva, and blood specimens from patients with ALK-positive lung cancer, along with clinical information about their disease and treatment.
Click on topic below for more information.